Milken webinar: Innovative financing models for antimicrobials
Note: I’ve been away on holiday (see the newsletter’s postscript) and so there are multiple new items in both the meetings calendar and the list
17 August 2026 No Comments
R&D Insight
Antimicrobial Effectiveness: The strategic economic value of antibiotics
Dear All (and with thanks to Lucy Naga for being the lead author on this economic-focused newsletter), Antimicrobials are the quiet safety net of modern
27 March 2026 No Comments
AWaRe antibiotic usage – Is 70% Access a good target?
Dear All: An important and instructive analysis of optimal global antibiotic usage targets has just been published in Lancet Public Health. To follow the plot,
22 July 2026 No Comments
DTR Gram-negative infections: Are new antibiotics making a difference?
Dear All (and with thanks to Aaron Dane for co-authoring this newsletter AND inhale, exhale … this is going to be a long, wonkish, but VERY
24 April 2026 No Comments
WHO: Virtual discussion on challenges of evidence generation
Dear All: WHO have announced a very interesting 2-h virtual dialogue on optimal evidence generation across the antibiotic R&D lifecycle! Here are the details you
16 July 2026 No Comments
WHO Webinars: Pediatric antibiotic R&D and Bacteriophage Community of Practice
Dear All: Two important webinars have just been announced! 22 July (virtual, 2-3.30p CET): The WHO AMR Department and the WHO GAP-r (Global Accelerator for
3 July 2026 No Comments
FDA guidance on Substantial Effectiveness; EMA concept paper on Evaluation of Antifungal Agents): Comments sought!
Dear All: Both FDA and EMA have very recently released important documents for comment. See below the links and commentary on the two documents. ==
5 July 2026 No Comments
Mirror Bacteria: An AMR threat of unprecedented magnitude
Dear All (wonkish but stick with it … I’m going to try very hard to de-wonk it; addendum: see also the follow-up newsletters, most recently
12 December 2024 No Comments
The threat of mirror bacteria: Ongoing conversations (2025 wrap-up)
Dear All, Regular readers will be aware of the global conversation now happening around the threat arising from the potential to create viable organisms that
22 December 2025 No Comments
Chemicals vs. drugs (Part 3): XKCD has the final word
This newsletter is part of a series — here are the links to Part 1, Part 2, (this one is Part 3), Part 4, and Part 5. You might
25 February 2020 No Comments